Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of urological disorders
3.2.1.2 Advancements in product formulations and delivery systems
3.2.1.3 Increasing emphasis on preventive healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 Potential interactions and side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Multi-ingredient
5.3 Single ingredient
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Urinary tract infections
6.3 Kidney health
6.4 Prostate health
6.5 Bladder health
Chapter 7 Market Estimates and Forecast, By Formulation, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Capsules
7.3 Softgels
7.4 Tablets
7.5 Powder
7.6 Other formulations
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Brick & mortar
8.3 E-commerce
Chapter 9 Company Profiles
9.1 Amway
9.2 Better Being Co.
9.3 dsm-firmenich
9.4 Himalaya Wellness Company
9.5 Himalayan Organics
9.6 Natrol, LLC
9.7 Nestle
9.8 Szio+
9.9 Theralogix
9.10 Uqora, Inc.
9.11 Zahler
